Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …

Background The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …

Global tuberculosis incidence has declined marginally over the past decade, and tuberculosis
remains out of control in several parts of the world including Africa and Asia. Although …

Rationale: Improving treatment outcomes while reducing drug toxicity and shortening the
treatment duration to ∼6 months remains an aspirational goal for the treatment of multidrug-…

Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs, …

The global tuberculosis burden remains substantial, with more than 10 million people newly
ill per year. Nevertheless, tuberculosis incidence has slowly declined over the past decade, …

Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …

Background. Patients with previous tuberculosis may have residual DNA in sputum that
confounds nucleic acid amplification tests such as Xpert MTB/RIF. Little is known about the …

Two in every five patients with active tuberculosis (TB) remain undiagnosed or unreported.
Therefore community-based, active case-finding strategies require urgent implementation. …

Background Assessing safety and efficacy of Covid-19 vaccines in different populations is
essential, as is investigation of efficacy against emerging SARS-CoV-2 variants of concern …